Skip to main content

Table 2 Analyses of expression levels of C-erbB-2, CXCR4, ER-a/β-actin (IOD) between pre- and post-therapy samples with western blotting

From: Decreased expression of C-erbB-2 and CXCR4 in breast cancer after primary chemotherapy

Parameters

Pre-chemotherapy specimens

Post-chemotherapy specimens

Z

p

C-erbB-2

0.546±0.182

0.442±0.142

-3.103

0.002

CXCR4

0.908±0.341

0.829±0.277

-2.689

0.002

ER-α

0.701±0.174

0.559±0.126

-3.516

0.00

  1. * p<0.05, compared with post-chemotherapy specimens